High-dose-rate-intracavitary brachytherapy applications and the difference in the bladder and rectum doses: a study from rural centre of Maharashatra, India.

Authors:

Vandana S Jain Mukund B Sarje Kailash K Singh R Umberkar Rajeev Shrivastava Shailendra M Jain

J Cancer Res Ther 2007 Apr-Jun;3(2):116-20

Department of Radiotherapy and Clinical Oncology, Pravara Rural University (Deemed University), Loni, BK-413 736, Ahmednagar, India.

Aim: To report the difference in the bladder and rectum doses with different applications by the radiotherapists in the same patient of the carcinoma of the uterine cervix treated by multiple fractions of high-dose-rate (HDR) intracavitary brachytherapy (ICBT).

Materials And Methods: Between January 2003 to December 2004, a total of 60 cases of the carcinoma uterine cervix were selected randomly for the retrospective analyses. All 60 cases were grouped in six groups according to the treating radiotherapist who did the HDR-ICBT application. Three radiotherapists were considered for this study, named A, B and C. Ten cases for each radiotherapist in whom all three applications were done by the same radiotherapist. And 10 cases for each radiotherapist with shared applications in the same patient (A+B, A+C and B+C). The bladder and rectal doses were calculated in reference to point "A" dose and were limited to 80% of prescribed point "A" dose, as per ICRU-38 recommendations. Received dose grouped in three groups--less then 80% (< 80%), 80-100% and above 100% (>100%). A total of 180 applications for 60 patients were calculated for the above analyses.

Results: There is a lot of difference in the bladder and rectal doses with the application by the different radiotherapists, even in the same patient with multiple fractions of HDR-ICBT. Applications by 'A' radiotherapist were within the limits in the self as well as in the shared groups more number of times, by 'B' radiotherapist was more times exceeding the limit and by 'C' radiotherapist doses were in between the A and B.

Discussion And Conclusion: For the rectal and bladder doses most important factors are patient's age, disease stage, duration between EBRT and HDR-ICRT and patient anatomy, but these differences can be minimized to some extent by careful application, proper packing and proper fixation.

Download full-text PDF	Source
http://dx.doi.org/10.4103/0973-1482.34693	DOI Listing

January 2008

Publication Analysis

Top Keywords

radiotherapists patient

treating radiotherapist

patient a+b

Keyword Occurance

Similar Publications

Development of an anthropomorphic multimodality pelvic phantom for quantitative evaluation of a deep-learning-based synthetic computed tomography generation technique.

Authors:

Hyeongmin Jin Sung Young Lee Hyun Joon An Chang Heon Choi Eui Kyu Chie Hong-Gyun Wu Jong Min Park Sukwon Park Jung-In Kim

J Appl Clin Med Phys 2022 May 17:e13644. Epub 2022 May 17.

Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea.

Purpose: The objective of this study was to fabricate an anthropomorphic multimodality pelvic phantom to evaluate a deep-learning-based synthetic computed tomography (CT) algorithm for magnetic resonance (MR)-only radiotherapy.

Methods: Polyurethane-based and silicone-based materials with various silicone oil concentrations were scanned using 0.35 T MR and CT scanner to determine the tissue surrogate. Read More

View Article and Full-Text PDF

May 2022

Similar Publications

Clinical features and predictive biomarkers for bladder cancer in patients with Type 2 Diabetes presenting with haematuria.

Authors:

C L Tonry R M Evans M W Ruddock Brian Duggan Oonagh McCloskey Alexander P Maxwell Declan O'Rourke Ruth E Boyd Joanne Watt Cherith N Reid David J Curry Michael Stevenson Margaret K Young Catherine S Jamison Joe Gallagher Stephen P Fitzgerald John Lamont Chris J Watson

Diabetes Metab Res Rev 2022 May 16:e3546. Epub 2022 May 16.

Wellcome Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, Northern, Ireland.

Aims: To identify clinical features and protein biomarkers associated with bladder cancer (BC) in individuals with type 2 diabetes mellitus presenting with haematuria.

Materials And Methods: Data collected from the Haematuria Biomarker (HaBio) study was used in this analysis. A matched sub-cohort of patients with type 2 diabetes and patients without diabetes was created based on age, sex and BC diagnosis, using approximately a 1:2 fixed ratio. Read More

View Article and Full-Text PDF

May 2022

Similar Publications

T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum.

Eur Urol Focus 2022 May 13. Epub 2022 May 13.

Department of Urology, Pitié Salpétrière Hospital, AP-HP, GRC no. 5, Oncotype-Uro, Sorbonne University, Paris, France.

Background: The pathological existence and clinical consequence of stage T1 grade 1 (T1G1) bladder cancer are the subject of debate. Even though the diagnosis of T1G1 is controversial, several reports have consistently found a prevalence of 2-6% G1 in their T1 series. However, it remains unclear if T1G1 carcinomas have added value as a separate category to predict prognosis within the non-muscle-invasive bladder cancer (NMIBC) spectrum. Read More

View Article and Full-Text PDF

May 2022

Similar Publications

Is Lymph Node Dissection Necessary During Radical Nephroureterectomy for Clinically Node-Negative Upper Tract Urothelial Carcinoma? A Multi-Institutional Study.

Front Oncol 2022 29;12:791620. Epub 2022 Apr 29.

Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

Purpose: This study aimed to compare the oncological outcomes of patients with upper tract urothelial carcinoma (UTUC) without clinical lymph node metastasis (cN0) undergoing lymph node dissection (LND) during radical nephroureterectomy (NU).

Methods: From the updated data of the Taiwan UTUC Collaboration Group, a total of 2726 UTUC patients were identified. We only include patients with ≥ pT2 stage and enrolled 658 patients. Read More

View Article and Full-Text PDF

April 2022

Similar Publications

Repeatability of Ultrasound-Defined Bladder Shape Metrics in Healthy Volunteers.

Authors:

Kaitlyn M Maddra Rui Li Anna S Nagle Adam P Klausner John E Speich

Res Rep Urol 2022 6;14:185-192. Epub 2022 May 6.

Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University College of Engineering, Richmond, VA, USA.

Purpose: Recent studies demonstrate the potential value of using non-invasive abdominal ultrasound to quantify bladder shape and its association with disorders of bladder filling and voiding. The aim of the present study was to assess the repeatability of ultrasound-defined bladder shape metrics within the same individual from multiple bladder fills and study visits.

Patients And Methods: Healthy volunteers completed an oral hydration protocol with two weekly visits, each with two consecutive bladder fill-void cycles, providing four total fills per participant. Read More

View Article and Full-Text PDF

May 2022

Similar Publications

}

Search Our Scientific Publications & Authors